Viridian Therapeutics (VRDN)'s 30-day implied volatility (IV30) was 47.7% at the close on November 16, 2026, up from 42.7% the day before, against a 52-week range of 27.9% to 177.5%. Its 20-day historical volatility was 55.3%.
Data as of November 16, 2026.